PIID: SPE2DR26FG1AFAWARDDELIVERY ORDERSmall Business
Delivery order SPE2DR26FG1AFAMERISOURCEBERGEN DRUG CORP
Recipient:AMERISOURCEBERGEN DRUG CORP
Overview
Award facts
Net obligations: $101,332
- Type
- Delivery order
- PIID
- SPE2DR26FG1AF
- Awarded by
- Department of Defense › Defense Logistics Agency › DLA TROOP SUPPORT
- Funded by
- Department of Defense
- Recipient
- AMERISOURCEBERGEN DRUG CORP (UEI KABZK8W6PQT3)CONSHOHOCKEN, PA
- Product or service (PSC)
- 6505 — DRUGS AND BIOLOGICALS
- Date
- Signed on Nov 13, 2025
- Period of performance
- Nov 13, 2025 to Dec 5, 2025 (potential end Dec 4, 2025)
- Options
- Base and all options value: $101,332
- Extent competed
- FULL AND OPEN COMPETITION
- Solicitation procedures
- NEGOTIATED PROPOSAL/QUOTE
- Set-aside
- No set-aside reported
- Contract pricing
- FIRM FIXED PRICE
- Place of performance
- CONSHOHOCKEN, PA
- Ordered under
- IDV SPE2DR25D3016 (5,747 orders recorded under it)
- Modifications
- 0; latest action Nov 13, 2025
- Obligations by fiscal year of action
- FY2026: $101,332
Description
4569997057!OCREVUS 300 MG/10 ML VIAL 10ML
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Jul 16, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 13, 2025. View on USAspending · Recipient on SAM.gov
Awardee
UEIKABZK8W6PQT3
CAGE code1XUY5
Business sizeOTHER THAN SMALL BUSINESS
Parent companyAMERISOURCEBERGEN CORPORATION
Transaction history
Transaction history
Every modification of this award, with its obligation change and reason.